Funded startups/Paralos Bioscience Inc.
PB

Paralos Bioscience Inc.

SEC filing
Biotechnology · Los Angeles, CA
Form D on EDGAR
Amount raised$647Ksold at filing
Total offering$1M$353K still open
Investors in the raise5count reported to the SEC
FiledJun 23, 2026first sale Jul 28, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Irene ChenExecutive Officer, Director
Yanxi YangExecutive Officer

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
D/AJun 23, 2026$647K$1MEDGAR
D/AApr 17, 2026$329K$1MEDGAR
D/ASep 24, 2025$150K$1MEDGAR
DAug 7, 2025$50K$1MEDGAR